Most Read News

On August 26, 2025, the business acquired 353,23,38,309 equity shares. These shares have a face value of $0.1005 each.

As per the company’s filing with the bourses, this is a one-time contract. This company plans to execute this order over financial years 2025-26 and 2026-27.

The project, expected to be completed within one year, involves an investment of ₹90 crore, to be funded entirely through internal accruals.

Anlon Healthcare Limited is an Indian pharmaceutical company specializing in the manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients (APIs).

The drug shall be used to treat diet and exercise for improvement of glycemic control in adults with type 2 diabetes.

iCaltech, an ISO 13485-certified medical device company, is engaged in the design, development and commercialisation of diagnostic products with a strong focus on respiratory applications

He also indicated that some large acquisitions are expected to close during this financial year, followed by a period of consolidation.

In addition, a 10:1 stock split has been cleared, dividing one equity share of ₹10 each into 10 shares of ₹1 each.

On August 26, 2025, the business received the commissioning certificate from the Rajasthan Renewable Energy Corporation Limited.

Hoteliers will be able to maintain consistent rates and availability across all booking platforms, reducing the chances of overbookings and pricing errors.